Literature DB >> 11702035

A new method for CHD prediction and prevention based on regional risk scores and randomized clinical trials; PRECARD and the Copenhagen Risk Score.

T F Thomsen1, M Davidsen, H Ibsen, T Jørgensen, G Jensen, K Borch-Johnsen.   

Abstract

BACKGROUND: There is a considerable gap between the recommended prevention of coronary heart disease (CHD) in the guidelines from the European Society of Cardiology and the actually conducted clinical practice in preventive cardiology. A new method for implementing the recommended clinical practice in preventive cardiology is described. AIM: To develop a comprehensive and flexible health educational computer program (the PRECARD program) for individual coronary risk prediction and multifactorial prevention.
MATERIAL AND METHODS: The PRECARD program contains a new coronary risk score (the Copenhagen Risk Score) for myocardial infarction and a model for calculating the effect of intervention. Two Danish population studies (n = 11,765) with 10 years of follow up were used to establish the risk score. The included risk factors were: age, sex, cholesterol (incl. HDL), systolic blood pressure, smoking, body mass index, diabetes, familial predisposition and previous heart disease. Nine randomized clinical trials were used to estimate the effect of intervention.
RESULTS: The findings in the Copenhagen Risk Score and the estimated effect of intervention deducted from the clinical trials were comparable to other similar studies. The PRECARD program gives a graphical or numerical presentation of absolute coronary risk, the potential benefit of intervention, the relative impact of modifiable risk factors and numbers needed to treat. The program compiles individually tailored health messages in print for the patient. The program can easily be adjusted to different regional risk scores, other end-points and languages.
CONCLUSION: The PRECARD program may promote the recommended clinical practice in preventive cardiology by serving as an integrated part of the lifestyle consultation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11702035     DOI: 10.1177/174182670100800508

Source DB:  PubMed          Journal:  J Cardiovasc Risk        ISSN: 1350-6277


  25 in total

1.  Sleep disturbances are related to decreased transmission of blue light to the retina caused by lens yellowing.

Authors:  Line Kessel; Galatios Siganos; Torben Jørgensen; Michael Larsen
Journal:  Sleep       Date:  2011-09-01       Impact factor: 5.849

Review 2.  Early Vascular Ageing - A Concept in Development.

Authors:  Peter M Nilsson
Journal:  Eur Endocrinol       Date:  2015-04-11

3.  Predicting major outcomes in type 1 diabetes: a model development and validation study.

Authors:  Sabita S Soedamah-Muthu; Yvonne Vergouwe; Tina Costacou; Rachel G Miller; Janice Zgibor; Nish Chaturvedi; Janet K Snell-Bergeon; David M Maahs; Marian Rewers; Carol Forsblom; Valma Harjutsalo; Per-Henrik Groop; John H Fuller; Karel G M Moons; Trevor J Orchard
Journal:  Diabetologia       Date:  2014-09-04       Impact factor: 10.122

Review 4.  Risk scoring for the primary prevention of cardiovascular disease.

Authors:  Kunal N Karmali; Stephen D Persell; Pablo Perel; Donald M Lloyd-Jones; Mark A Berendsen; Mark D Huffman
Journal:  Cochrane Database Syst Rev       Date:  2017-03-14

5.  Multidisciplinary structured lifestyle intervention reduces the estimated risk of cardiovascular morbidity and mortality.

Authors:  R L H Sprangers; F Stam; H E C Smid; C D A Stehouwer; I M Hellemans
Journal:  Neth Heart J       Date:  2004-10       Impact factor: 2.380

6.  Cardiovascular risk prediction tools for populations in Asia.

Authors:  F Barzi; A Patel; D Gu; P Sritara; T H Lam; A Rodgers; M Woodward
Journal:  J Epidemiol Community Health       Date:  2007-02       Impact factor: 3.710

7.  Risk of cardiovascular disease in HIV, hepatitis C, or HIV/hepatitis C patients compared to the general population.

Authors:  L Kakinami; R C Block; M J Adams; S E Cohn; B Maliakkal; S G Fisher
Journal:  Int J Clin Pract       Date:  2013-01       Impact factor: 2.503

Review 8.  Heart rate control with adrenergic blockade: clinical outcomes in cardiovascular medicine.

Authors:  David Feldman; Terry S Elton; Doron M Menachemi; Randy K Wexler
Journal:  Vasc Health Risk Manag       Date:  2010-06-01

9.  RESPONSE study: Randomised Evaluation of Secondary Prevention by Outpatient Nurse SpEcialists: Study design, objectives and expected results.

Authors:  H T Jørstad; A M W Alings; A H Liem; C von Birgelen; J G P Tijssen; C J de Vries; D J A Lok; J A Kragten; R J G Peters
Journal:  Neth Heart J       Date:  2009-09       Impact factor: 2.380

10.  The CHANGE trial: no superiority of lifestyle coaching plus care coordination plus treatment as usual compared to treatment as usual alone in reducing risk of cardiovascular disease in adults with schizophrenia spectrum disorders and abdominal obesity.

Authors:  Helene Speyer; Hans Christian Brix Nørgaard; Merete Birk; Mette Karlsen; Ane Storch Jakobsen; Kamilla Pedersen; Carsten Hjorthøj; Charlotta Pisinger; Christian Gluud; Ole Mors; Jesper Krogh; Merete Nordentoft
Journal:  World Psychiatry       Date:  2016-06       Impact factor: 49.548

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.